| 000 | 01917cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030229.0 | ||
| 008 | 100518s2010 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2010.Ma.P | ||
| 100 | 0 | _aMagda Abdelwahed Desouki | |
| 245 | 1 | 0 |
_aPolymorphisms of the drug - metabolizing enzyme CYP1A1 and susceptibility to B - cell non - hodgkin lymphoma / _cMagda Abdelwahed Desouki ; Supervised Shahira Amin Zayed , Ola Mohamed Khorshid , Sarah Adel Labib |
| 246 | 1 | 5 | _aالتعدد الشكلى لجين الانزيم CYP1A1الخاص بتأيض العقاقير وقابلية الاصابة بسرطان الغدد الليمفاوية اللاهودجكينى(خلايا - ب) |
| 260 |
_aCairo : _bMagda Abdelwahed Desouki , _c2010 |
||
| 300 |
_a147P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aThe incidence of NHL has been steadily rising as a possible result of environmental carcinogens exposure . We aimed at determining whether polymorphisms of drug - metabolizing enzyme CYP1A1 increase susceptibility to B - cell NHL . Two CYP1A1 gene polymorphisms (3801[T > C] and 4889 [A > G] ) were analyzed in 50 DLBCL patients and 25 controls using polymerase chin reaction - restriction fragment length polymorphism (PCR - RFLP ) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCYP1A1 | |
| 653 | 4 | _aDrug - metabolizing enzyme | |
| 653 | 4 | _aPolymorphism | |
| 700 | 0 |
_aOla Mohamed Khorshid , _eSupervisor |
|
| 700 | 0 |
_aSarah Adel Labib , _eSupervisor |
|
| 700 | 0 |
_aShahira Amin Zayed , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30332 _d30332 |
||